All In Biotech

Drug Trial Radar · NCT04568434

A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) Administered to Patients With Familial Chylomicronemia Syndrome (FCS)

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of AKCEA-APOCIII-LRx Administered Subcutaneously to Patients With Familial Chylomicronemia Syndrome (FCS)

Last checked: Nov 20, 2026Latest source record: Mar 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

66

Actual

Start

Nov 18, 2020

Primary completion

Jul 14, 2023

Study completion Oct 17, 2023

Sponsor

Lead sponsor
Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals (IONS)
Sponsor type
Industry
First posted
Sep 29, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study was to evaluate the efficacy of olezarsen as compared to placebo on the percent change in fasting triglycerides (TG) from baseline.

Conditions

  • Familial Chylomicronemia Syndrome

Interventions

  • OlezarsenDrug

    Olezarsen was administered by SC injection.

  • PlaceboDrug

    Olezarsen-matching placebo was administered by SC injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change From Baseline in Fasting TG at Month 6Time frame: Baseline, Month 6

Locations

47 sites in 11 countries. Site status is shown where the registry gives one.

  • Diabetes/Lipid Management & Research Center

    Huntington Beach, California

  • University of California, San Francisco (UCSF) - Medical Center

    San Francisco, California

  • Excel Medical Clinical Trials, LLC

    Boca Raton, Florida

  • NorthShore University Health System

    Evanston, Illinois

  • Advocate Health and Hospitals Corporation - Lutheran General Hospital

    Park Ridge, Illinois

  • Ascension St. Vincent Cardiovascular Research Institute

    Indianapolis, Indiana

  • University of Kansas Medical Center (KUMC)

    Kansas City, Kansas

  • University of Michigan- Endocrinology & Metabolism

    Ann Arbor, Michigan

  • New York University (NYU) Langone Medical Center

    New York, New York

  • Columbia University Medical Center

    New York, New York

  • Moses H. Cone Memorial Hospital

    Greensboro, North Carolina

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Vanderbilt University

    Nashville, Tennessee

  • University of Texas Southwestern

    Dallas, Texas

  • Baylor College of Medicine

    Houston, Texas

  • York Clinical Research LLC

    Norfolk, Virginia

  • West Virginia University Heart and Vascular Institute

    Morgantown, West Virginia

  • Institute de Recherches Cliniques de Montreal

    Montreal, Canada

  • Ecogene-21

    Chicoutimi, Quebec, Canada

  • Nathalie Saint-Pierre

    Montreal, Quebec, Canada

  • Clinique des Maladies Lipidiques de Quebec Inc.

    Québec, Quebec, Canada

  • Hôpital Louis Pradel - HCL

    Bron, France

  • CHU Dijon - Bocage

    Dijon, France

  • Assistance Publique - Hopitaux de Marseille

    Marseille, France

  • ASST Grande Ospedale Metropolitano Niguarda

    Milan, Italy

  • Azienda Ospedaliera Universitaria Federico II

    Naples, Italy

  • Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone

    Palermo, Italy

  • Azienda Ospedaliero Universitaria Policlinico Umberto I

    Roma, Italy

  • Academic Medical Center - Department of Vascular Medicine

    Amsterdam, Netherlands

  • Erasmus MC

    Rotterdam, Netherlands

  • Universitair Medisch Centrum Utrecht

    Utrecht, Netherlands

  • The Lipid Clinic (Oslo University Hospital)

    Oslo, Norway

  • Centro Hospitalar de Lisboa Ocidental. E.P.E, - Hospital Santa Cruz

    Carnaxide, Portugal

  • Hospital da Senhora da Oliveira - Guimaraes

    Creixomil, Portugal

  • Centro Hospitalar de Lisboa Ocidental, EPE - Hospital Egas Moniz

    Lisbon, Portugal

  • Metabolicke centrum MUDr Katariny Raslovej s. r. o.

    Bratislava, Slovakia

  • Hospital Abente y Lago

    A Coruña, Spain

  • Hospital Clinic Barcelona

    Barcelona, Spain

  • Hospital Universitario 12 de Octubre

    Madrid, Spain

  • Hospital Universitario Virgen del Rocio

    Seville, Spain

Showing 40 of 47 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.